Holt, attorney and owner of Holt Law, a health-care business law firm in Minnesota and California, points out that it was moved to Category 2 in 2023, so legally, compounding pharmacies cannot distribute it for human use. But theyre using that for research purposes loophole to distribute it
So are GLP-1 medications that treat obesity and type 2 diabetes (among other diseases)
For Canadian researchers following the metabolic peptide field, cagrilintide and the amylin analog category warrant attention as the field continues to expand beyond single, dual, and triple agonist compounds
Heres what you can expect from your B12 injection appointment: Consultation Before administering B12 injections, our experienced medical providers will conduct a thorough consultation to understand your health history, current symptoms, and wellness goals